Learn more at LeadIQ.com

Insights

Innovative Medicines DICE Therapeutics focuses on designing and developing innovative oral medicines for chronic autoimmune and inflammatory diseases. This presents a sales opportunity in the healthcare market for potential partnerships or licensing agreements.

Exceptional Leadership Team The company is led by a team with a proven track record in progressing programs from discovery to commercialization. Leveraging these seasoned executives can be a strategic advantage to establish business relationships in the pharmaceutical industry.

Technological Infrastructure DICE Therapeutics utilizes a modern tech stack including JazzHR, WordPress, and Webflow. Understanding their technology landscape can help identify potential integration services or solutions for improved efficiency and collaboration.

Revenues and Growth With reported revenues between $0-10M, there is growth potential for DICE Therapeutics. Engaging with the company at this stage can offer opportunities for sales growth through tailored solutions that support their expansion.

Competitive Landscape Comparing to similar companies like Roche and Bristol Myers Squibb, DICE Therapeutics stands out with its focused approach. Analyzing this competitive positioning can guide sales strategies to highlight unique selling points and differentiate offerings.

Similar companies to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company Tech Stack

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company uses 8 technology products and services including JazzHR, WordPress, Modernizr, and more. Explore DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's tech stack below.

JazzHR
Applicant Tracking Systems
WordPress
Content Management System
Modernizr
Javascript Libraries
jQuery Migrate
Javascript Libraries
LottieFiles
Miscellaneous
Webflow
Page Builders
Lua
Programming Languages
Coupa
Travel And Expense Management

Media & News

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's Email Address Formats

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company uses at least 2 format(s):

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company Email Formats	Example	Percentage
FLast@dicemolecules.com	JDoe@dicemolecules.com	96%
First@dicemolecules.com	John@dicemolecules.com	2%
LFirst@dicemolecules.com	DJohn@dicemolecules.com	1%
Last@dicemolecules.com	Doe@dicemolecules.com	1%
FLast@dicetherapeutics.com	JDoe@dicetherapeutics.com	100%

Frequently Asked Questions

Where is DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's headquarters located?

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's main headquarters is located at 279 E. Grand Avenue South San Francisco, CA 94080 US. The company has employees across 4 continents, including North AmericaEuropeAfrica.

What is DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's phone number?

You can contact DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's main corporate office by phone at

+1-650-566-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's official website and social media links?

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's official website is dicetherapeutics.com and has social profiles on LinkedIn.

How much revenue does DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company generate?

As of March 2024, DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's annual revenue reached $1.1M.

What is DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's SIC code NAICS code?

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company have currently?

As of March 2024, DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company has approximately 67 employees across 4 continents, including North AmericaEuropeAfrica. Key team members include Chief Executive Officer: K. J.Chief Medical Officer: T. L.Chief Scientific Officer: J. J.. Explore DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's employee directory with LeadIQ.

What industry does DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company belong to?

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company operates in the Biotechnology Research industry.

What technology does DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company use?

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's tech stack includes JazzHRWordPressModernizrjQuery MigrateLottieFilesWebflowLuaCoupa.

What is DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's email format?

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's email format typically follows the pattern of . Find more DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company email formats with LeadIQ.

When was DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company founded?

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company was founded in 2013.

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company

Biotechnology ResearchCalifornia, United States51-200 Employees

At DICE, we are expecting more out of medicine. We design and develop innovative oral medicines against biologically validated targets in immunology for the treatment of chronic autoimmune and inflammatory diseases. Through combining innovative chemistry with well-validated biology, our goal is to make medicines more accessible and unlock the potential of oral medicines.

Our team is led by an exceptional group of scientists, R&D executives and company builders with demonstrated track records of progressing programs from discovery through regulatory approval and commercialization. Together, we’re building a team that has a passion for innovation and extensive experience in small molecule drug discovery and development.

Company Overview

Headquarters: 279 E. Grand Avenue South San Francisco, CA 94080 US
Phone number: ✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-650-566-****
Website: dicetherapeutics.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2013
Employees: 51-200

Media & News

Funding & Financials

$10M
DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's revenue is in the range of $10M

Funding & Financials

$10M
DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's revenue is in the range of $10M

Company Leadership

K. J.
Chief Executive Officer
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. L.
Chief Medical Officer
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. J.
Chief Scientific Officer
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. P.
Vice President Information Technology
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. O.
Vice President Regulatory
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

T. S.
Executive Assistant To Chief Executive Officer & Chief Financial Officer
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. G.
Senior Vice President, Biology
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. C.
Associate Vice President, Development Operations
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. D.
Senior Director - Head Of Pharmaceutical Development
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. P.
Vice President Information Technology
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company and Millions of Other Companies
Sign up for full access to DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.